The bullish CDMO CEO making bold moves

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jeremie Trochu, CEO at Ardena.

Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Jeremie, covering:

• The value of hitting the road and getting in front of clients, helping build several career-critical skills
• The big decision to leave med-tech giant GE and move to an ambitious, growing CDMO called...Catalent
• How the stars aligned to move back to Europe and join Ardena as CEO...and the secret sauce behind its suite of integrated development capabilities
• A transformational acquisition of Catalent's Somerset, NJ facility to help take Ardena to the next level as a global CDMO
• The importance of remembering that we are part of a cyclical industry and must ride out the lows, but we must remain adaptive and bullish about the market's growth
• Why VUCA (volatility, uncertainty, complexity, ambiguity) is inevitable

Jeremie joined Ardena as Chief Executive Officer in June 2024. He brings an extensive knowledge of the life sciences and CDMO industry and a proven track record of success in the biopharma sector. He has 20 years of experience building and growing businesses globally, expanding into new markets, and leading large-scale transformations in publicly traded and privately held companies. 

Jeremie was previously part of the team that helped transform Catalent from a private equity spinoff into a publicly traded global CDMO. During his tenure there, he led multiple companies' successful acquisitions and integrations. He holds a master's degree in Business Administration from EMLyon, France.

Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!

Molecule to Market is also sponsored and funded by ramarketing, an international marketing, design, digital and content agency helping companies differentiate, get noticed and grow in life sciences.